Close menu



Avelumab-like - Labelled (Arg,Lys) 13C15N


Quantification of Avelumab

Specific labelling

Arginine: 13C6,15N4>99%

Lysine: 13C6,15N2, >99%


Labelled Avelumab-like is a recombinant, stable isotope labelled monoclonal IgG1-Lambda antibody containing proteotypic peptides derived from Avelumab’s originator sequence. Labelled Avelumab-like is designed for use as an internal standard for quantitative analysis of Avelumab in plasma samples. Avelumab targets the immune checkpoint programmed death-ligand 1 (PD-L1) and is used to treat a number of cancers.

This product is for research use only and is not intended for diagnostic or therapeutic use.